Monthly Prescribing Reference

Spiriva Respimat Gains Indication and New Dosage Strength

Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) is now available for the long-term maintenance treatment of asthma in patients ages ≥12 years. Boehringer Ingelheim announced ...
FiercePharma

SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available in the United States

SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
Monthly Prescribing Reference

Spiriva Respimat Gets Expanded Approval for Pediatric Asthma Maintenance

This approval was based on efficacy and safety data from the Phase 2 and Phase 3 UniTinA-asthma clinical development program. The Food and Drug Administration (FDA) has approved Spiriva Respimat ...
Yahoo

New Analyses: Adding SPIRIVA® Respimat® Effective for Uncontrolled Asthma – Regardless of Allergy Subtype1,2,3

New analyses show improved lung function * and asthma symptom control and reduced asthma exacerbations for patients with allergic asthma 1,2,3 These analyses evaluated the safety and efficacy of ...
The Financial

Adding SPIRIVA Respimat Effective for Uncontrolled Asthma – Regardless of Allergy Subtype

The FINANCIAL — Boehringer Ingelheim on March 8 announced the presentation of new post-hoc analyses that show the addition of SPIRIVA (tiotropium) Respimat to other asthma maintenance therapies helps ...
FiercePharma

FDA Approves Boehringer Ingelheim's SPIRIVA RESPIMAT for the Maintenance Treatment of Asthma in Adults and Adolescents

RIDGEFIELD, Conn., September 16, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, ...
News Medical

Spiriva Respimat (with dose indicator)

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Spiriva Respimat contains the active ingredient tiotropium. Spiriva ...
FierceBiotech

FDA Advisory Committee Recommends Approval of Tiotropium Respimat® for the Maintenance Treatment of COPD

RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee ...
Business Insider

FDA Approves Stiolto® Respimat® Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction

RIDGEFIELD, Conn., Oct. 11, 2018 /PRNewswire/ -- Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) approved new labeling for Stiolto Respimat (tiotropium bromide & ...
Business Wire

Global Spiriva (Tiotropium; Boehringer Ingelheim) Market Analysis & Forecast 2017-2026 with Sales Revenue by Country - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spiriva" report has been added to ResearchAndMarkets.com's offering. Spiriva (tiotropium; Boehringer Ingelheim) is a long-acting muscarinic antagonist (LAMA) approved for ...
The American Journal of Managed Care

Head-to-Head Study Results About Two COPD Inhalers Gives One an Edge

A study of 2 chronic obstructive pulmonary disease (COPD) inhalers from the same company was published recently in The Lancet Respiratory Medicine. The DYNAGITO trial showed tiotropium bromide and ...